首页> 外文期刊>The journal of obstetrics and gynaecology research >Does pre‐eclampsia without proteinuria lead to different pregnancy outcomes than pre‐eclampsia with proteinuria?
【24h】

Does pre‐eclampsia without proteinuria lead to different pregnancy outcomes than pre‐eclampsia with proteinuria?

机译:没有蛋白尿的预先是异普拉明裔人会导致不同的妊娠晚期,而不是蛋白尿预先引起的蛋白尿?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Aims The Japanese Society for the Study of Hypertension in Pregnancy revised the diagnostic criteria for pre‐eclampsia (PE) to conform to those of the International Society for the Study of Hypertension in Pregnancy (ISSHP) in 2018. This study aimed to investigate whether pregnancy outcomes differ based on the presence of proteinuria and validate the adoption of the ISSHP criteria in Japan. Methods This is a retrospective study involving 308 women diagnosed with hypertensive disorders of pregnancy at a tertiary center. They were divided into the following groups: PE with proteinuria ( n = 218), PE without proteinuria ( n = 45) and gestational hypertension ( n = 45) according to the ISSHP criteria for comparison of pregnancy outcomes. Results Applying the ISSHP criteria increased the number of pregnant women diagnosed as having PE by 14.6% (45 women). The difference in the rate of composite maternal complications between the two groups was unremarkable, with 33 cases (15.1%) in the PE with proteinuria group and 9 cases (20%) in the PE without proteinuria group. Moreover, composite neonatal complications occurred in 37 cases (17%) of PE with proteinuria group and 6 cases (13.3%) of PE without proteinuria group, showing remarkably similar incidence rate in the two groups. Women with PE with and without proteinuria had significantly earlier deliveries and lower neonatal birth weight than those with gestational hypertension. Conclusion Pregnancy outcomes of PE with and without proteinuria were almost similar although their incidence increased, confirming its validity for adaptation of the ISSHP criteria in Japan.
机译:摘要旨在将日本妊娠期高血压学会进行了修订了预测前普利克斯(PE)的诊断标准,符合2018年妊娠期(ISSHP的高血压研究社会的诊断标准。该研究旨在调查是否怀孕结果基于蛋白尿存在,并验证日本的ISSHP标准的采用。方法是,这是一项涉及308名妇女在第三中心诊断出患有高血压性妊娠期妊娠的女性。它们分为以下组:根据ISSHP标准进行蛋白尿(n = 218),PE,没有蛋白尿(n = 45)和妊娠期高血压(n = 45),以进行妊娠结果。结果应用ISSHP标准增加了患有14.6%(45名妇女)诊断为PE的孕妇数量。两组之间的复合母体并发症率的差异未解开,33例(15.1%)在蛋白尿组中的PE和PE中的9例(20%),没有蛋白尿组。此外,复合新生儿并发症发生在37例(17%)的PE,蛋白尿组和6例(13.3%)的PE,无蛋白尿组,在两组中显示出显着的发病率。具有和不含蛋白尿的PE的女性显着提前递送和降低新生儿出生体重而不是妊娠高血压。结论患有蛋白尿的PE妊娠晚期几乎相似,尽管它们的发病率增加,但确认其对日本的ISSHP标准的适应性有效性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号